Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Videla

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 12, 2025
Amyloid-negative neuropsychological norms: Added value in the era of biomarkers and disease-modifying therapiesSara Rubio-Guerra, Isabel Sala, María Belén Sánchez-Saudinós, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 29, 2026
Peak width of skeletonized mean diffusivity reveals early and multifactorial white matter injury across sporadic and Down syndrome-associated Alzheimer's diseaseAlejandra O Morcillo-Nieto, Maria Franquesa-Mullerat, Sara E Zsadanyi, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 12, 2025
Development of amyloid-negative neuropsychological norms using GAMLSSSara Rubio-Guerra, María Belén Sánchez-Saudinós, Isabel Sala, et al.
JAMA Neurology|July 6, 2021
Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down SyndromeAlexandre Bejanin, Maria Florencia Iulita, Eduard Vilaplana, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersJudit Selma-Gonzalez, Sara Rubio-Guerra, Jesús Garcia Castro, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 27, 2025
Validation of the CAMCOG-DS-II, a neuropsychological test battery for Alzheimer's disease in people with Down syndrome: A Horizon 21 European Down syndrome Consortium studyPhoebe Ivain, Asaad Baksh, Fedal Saini, et al.
Brain Communications|April 14, 2023
Association of biological sex with clinical outcomes and biomarkers of Alzheimer's disease in adults with Down syndromeM Florencia Iulita, Alexandre Bejanin, Eduard Vilaplana, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2019
The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disordersDaniel Alcolea, Jordi Clarimón, María Carmona-Iragui, et al.
Nature Medicine|January 6, 2026
A minimally invasive dried blood spot biomarker test for the detection of Alzheimer's disease pathologyHanna Huber, Laia Montoliu-Gaya, Wagner S Brum, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 17, 2025
The Down Alzheimer Barcelona Neuroimaging Initiative (DABNI) and its contributions to understanding Alzheimer's disease in Down syndrome: A decade of discoveryLaura Videla, Bessy Benejam, Isabel Barroeta, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 12, 2025
Amyloid-negative neuropsychological norms: Added value in the era of biomarkers and disease-modifying therapiesSara Rubio-Guerra, Isabel Sala, María Belén Sánchez-Saudinós, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 29, 2026
Peak width of skeletonized mean diffusivity reveals early and multifactorial white matter injury across sporadic and Down syndrome-associated Alzheimer's diseaseAlejandra O Morcillo-Nieto, Maria Franquesa-Mullerat, Sara E Zsadanyi, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 12, 2025
Development of amyloid-negative neuropsychological norms using GAMLSSSara Rubio-Guerra, María Belén Sánchez-Saudinós, Isabel Sala, et al.
JAMA Neurology|July 6, 2021
Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down SyndromeAlexandre Bejanin, Maria Florencia Iulita, Eduard Vilaplana, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersJudit Selma-Gonzalez, Sara Rubio-Guerra, Jesús Garcia Castro, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 27, 2025
Validation of the CAMCOG-DS-II, a neuropsychological test battery for Alzheimer's disease in people with Down syndrome: A Horizon 21 European Down syndrome Consortium studyPhoebe Ivain, Asaad Baksh, Fedal Saini, et al.
Brain Communications|April 14, 2023
Association of biological sex with clinical outcomes and biomarkers of Alzheimer's disease in adults with Down syndromeM Florencia Iulita, Alexandre Bejanin, Eduard Vilaplana, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2019
The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disordersDaniel Alcolea, Jordi Clarimón, María Carmona-Iragui, et al.
Nature Medicine|January 6, 2026
A minimally invasive dried blood spot biomarker test for the detection of Alzheimer's disease pathologyHanna Huber, Laia Montoliu-Gaya, Wagner S Brum, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 17, 2025
The Down Alzheimer Barcelona Neuroimaging Initiative (DABNI) and its contributions to understanding Alzheimer's disease in Down syndrome: A decade of discoveryLaura Videla, Bessy Benejam, Isabel Barroeta, et al.
Pageof 9